Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Revenue Gross Profit Operating Income EBITDA Net Income Shares Outstanding

Eli Lilly annual other operating income or expenses for 2024 were $-0.861B, a 1171.2% increase from 2023.
Eli Lilly annual other operating income or expenses for 2023 were $-0.068B, a 72.32% decline from 2022.
Eli Lilly annual other operating income or expenses for 2022 were $-0.245B, a 22.62% decline from 2021.

Eli Lilly Other Operating Income or Expenses 2010-2025 | LLY

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Revenue Gross Profit Operating Income EBITDA Net Income Shares Outstanding

Eli Lilly annual other operating income or expenses for 2024 were $-0.861B, a 1171.2% increase from 2023.
Eli Lilly annual other operating income or expenses for 2023 were $-0.068B, a 72.32% decline from 2022.
Eli Lilly annual other operating income or expenses for 2022 were $-0.245B, a 22.62% decline from 2021.